Open original FDA record ↗Recall record
- FDA identifier
- Z-3119-2017
- Company in FDA record
- bioMerieux, Inc.
- FDA record creation date
- Sep 12, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Some anomalies have been identified during manufacturing controls.
Source facts
- Action
- The firm, Biomerieux, sent an "IMPORTANT: URGENT PRODUCT SAFETY CORRECTION NOTICE" letter on 4/10/2017 to its Consignees. The letter described the product, problem and actions to be taken. The Consignees were instructed to distribute this information to all appropriate personnel; retain copy for files; forward information to all parties that may use this product; perform a Main Board Re-initialization after each weekly maintenance; and complete and return the Acknowledgment Form by Fax to + 33 (0) 04 78 87 73 07 to confirm receipt of notice. A Field Service engineer will come on site to check the unit. If you require additional assistance or have any questions, please contact your local bioMrieux Customer Service representative or call 919-620-3396 or email: tiffiany.mentzel@biomerieux.com.
- Initiated
- 2017-04-10
- Root cause
- Unknown/Undetermined by firm
- Terminated
- 2022-02-24
- Distribution
- Worldwide Distribution: US (nationwide) to states of: GA, IL, IN, MA, NC & TX and to countries of: Austria, France, Germany, Hong Kong, Italy, Netherlands, Spain, Sweden, Switzerland, Thailand and United Kingdom.
- Recall number
- Z-3119-2017
- Recall status
- Terminated
- CDRH record ID
- 158456
- FDA record created
- 2017-09-12
- Recall event number
- 77989